FRANK E THOMAS

CIK 1242616 · See Remarks · last filed 2026-05-20

FRANK E THOMAS is a corporate insider who has filed 64 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for LRMR, was dated May 20, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $238.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$238.0K

Companies

6

Total Filings

64

Lifetime Open-Market Net

-$2.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LRMR Director 7,000 $3.47 $24.3K $47.0K 9 2026-05-20
SPRO Director 75,000 $2.85 $213.8K $0 11 2025-06-16
Orchard Therapeutics plc (ORTX) Delisted See Remarks 0 $16.70 $0 $7.5K 13 2024-01-24
Larimar Therapeutics, Inc. (ZFGN) Delisted Director $0 5 2019-06-27
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted President & COO 138,195 -$2.59M 21 2017-02-27
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted President & CEO 72,033 $1.95 $140.5K $10.6K 5 2007-08-22

Recent Filings

64 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-20 LRMR Grant (A) $0 EDGAR
2026-03-02 LRMR Buy (P) +5,000 $25.0K EDGAR
2025-06-16 SPRO Grant (A) +20,000 $0 EDGAR
2025-05-14 LRMR Grant (A) $0 EDGAR
2024-05-31 LRMR Grant (A) $0 EDGAR
2024-05-30 SPRO Grant (A) +20,000 $0 EDGAR
2024-02-15 LRMR Buy (P) +2,000 $22.0K EDGAR
2024-01-24 Orchard Therapeutics plc (ORTX) Delisted Disp (D) −92,081 $0 EDGAR
2023-10-10 SPRO Grant (A) +20,000 $0 EDGAR
2023-05-11 LRMR Grant (A) $0 EDGAR
Showing 110 of 64
Page 1 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.